iconiifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Zydus and Torrent ink pact to co-market Saroglitazar for liver diseases

13 Nov 2023 , 10:43 AM

Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited have collaborated on a licensing and supply arrangement to co-market Saroglitazar Mg in India, which is used to treat Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD).

According to a press release, Saroglitazar Magnesium, the country's sole licensed medicine for NASH and NAFLD, is anticipated to play a crucial role in treating and reducing severe liver illnesses.

Torrent receives semi-exclusive rights to co-market the product as VORXAR under this deal. The original creator, Zydus, will continue to commercialize the medicine under the brand names Lipaglyn and Bilypsa. Torrent will pay Zydus upfront licensing fees as well as milestone payments based on preset milestones.

The drug aroglitazar Mg, which has been approved by India's Drugs Controller General, is a breakthrough in the treatment of chronic liver disorders such as NASH and NAFLD. It is the first medicine approved in any country for these disorders. There is currently no other licensed medicine in the world for NASH and NAFLD.

Saroglitazar Magnesium is a substantial development in NASH and NAFLD, illness regions with high prevalence and limited clinically supported treatment alternatives.  This will strengthen the company's gastrointestinal business while also addressing growing unmet patient requirements.

For feedback and suggestions, write to us at editorial@iifl.com


Related Tags

  • Torrent
  • Torrent News
  • Torrent Updates
  • Zydus
  • Zydus News
  • Zydus Updates
sidebar mobile


Read More

Most Read News

4 Mar 2024   |   09:10 AM
4 Mar 2024   |   06:22 PM
4 Mar 2024   |   08:40 AM
4 Mar 2024   |   06:37 PM
Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.